Detalles de la búsqueda
1.
Relapse Rates With Paliperidone Palmitate in Adult Patients With Schizophrenia: Results for the 6-Month Formulation From an Open-label Extension Study Compared to Real-World Data for the 1-Month and 3-Month Formulations.
Int J Neuropsychopharmacol
; 27(2)2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38300235
2.
Effects of esketamine nasal spray on depressive symptom severity in adults with treatment-resistant depression and associations between the Montgomery-Åsberg Depression Rating Scale and the 9-item Patient Health Questionnaire.
CNS Spectr
; 29(3): 176-186, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38557430
3.
Adverse Events and Measurement of Dissociation After the First Dose of Esketamine in Patients With TRD.
Int J Neuropsychopharmacol
; 26(3): 198-206, 2023 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36525338
4.
Long-Term Efficacy and Safety of Paliperidone 6-Month Formulation: An Open-Label 2-Year Extension of a 1-Year Double-Blind Study in Adult Participants With Schizophrenia.
Int J Neuropsychopharmacol
; 26(8): 537-544, 2023 08 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37480362
5.
Treatment response to esketamine nasal spray in patients with major depressive disorder and acute suicidal ideation or behavior without evidence of early response: a pooled post hoc analysis of ASPIRE.
CNS Spectr
; : 1-7, 2022 Jul 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35904046
6.
Esketamine Nasal Spray for the Rapid Reduction of Depressive Symptoms in Major Depressive Disorder With Acute Suicidal Ideation or Behavior.
J Clin Psychopharmacol
; 41(5): 516-524, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34412104
7.
Clinically meaningful changes on depressive symptom measures and patient-reported outcomes in patients with treatment-resistant depression.
Acta Psychiatr Scand
; 143(3): 253-263, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249552
8.
The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
Depress Anxiety
; 38(11): 1120-1130, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34293233
9.
Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Int J Neuropsychopharmacol
; 23(7): 426-433, 2020 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32270176
10.
Application of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modification.
Pharm Stat
; 18(1): 22-38, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221459
11.
Global sensitivity analysis for repeated measures studies with informative drop-out: A semi-parametric approach.
Biometrics
; 74(1): 207-219, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28542799
12.
Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.
J Nerv Ment Dis
; 205(4): 324-328, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28005578
13.
Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder.
J Clin Psychopharmacol
; 36(4): 372-6, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27322760
14.
Body mass index and metabolic parameters in patients with schizophrenia during long-term treatment with paliperidone palmitate.
BMC Psychiatry
; 14: 52, 2014 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24559194
15.
Efficacy and Safety of Ponesimod Compared with Teriflunomide in Female Patients with Relapsing Multiple Sclerosis: Findings from the Pivotal OPTIMUM Study.
J Womens Health (Larchmt)
; 33(4): 480-490, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301149
16.
Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies.
Ann Gen Psychiatry
; 12(1): 22, 2013 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23845018
17.
Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.
J Affect Disord
; 321: 153-160, 2023 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273682
18.
Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia.
Ther Adv Psychopharmacol
; 13: 20451253231200258, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37786804
19.
Feasibility study to evaluate capabilities for conducting psychiatric clinical research within the Rwandan mental healthcare system.
BMJ Open
; 13(4): e064675, 2023 04 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37072361
20.
Earlier Use of Long-Acting Injectable Paliperidone Palmitate Versus Oral Antipsychotics in Patients With Schizophrenia: An Integrated Patient-Level Post Hoc Analysis.
J Clin Psychiatry
; 84(6)2023 Sep 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37756123